Literature DB >> 26993396

The calf muscle pump revisited.

Katherine J Williams1, Olufemi Ayekoloye2, Hayley M Moore1, Alun H Davies3.   

Abstract

BACKGROUND: Chronic venous disease (CVD) defines the spectrum of manifestations of venous disease that originate as a result of ambulatory venous hypertension. Thus far, the role of the calf muscle pump in the development and potentiation of CVD has been overlooked and understated in the clinical setting, with much greater emphasis placed on reflux and obstruction. The aim of this review is to explore the level of significance that calf muscle pump function or dysfunction bears on the development and potentiation of CVD.
METHODS: EMBASE and MEDLINE databases were searched with keywords "calf" AND "muscle" AND "pump" AND "venous" AND "insufficiency" AND ("lower limb*" OR "leg*"), screened for cross-sectional and longitudinal studies relating to chronic venous insufficiency, highlighting the role of the calf muscle pump in CVD and the extent to which the calf muscle pump is impaired in these cases. This resulted in the inclusion of 10 studies.
RESULTS: Compared with healthy subjects, patients with CVD have a reduced ejection fraction (15.9%; P < .001) and an increased venous filling index (4.66 mL/s; P < .001), indicating impairment in calf muscle pump ejection ability as well as poor venous competence. Calf muscle pump dysfunction is present in 55% of patients with CVD in the literature, but this did not reach significance on meta-analysis. Isotonic exercise programs in patients with active and healed ulcers have been shown to increase calf muscle pump function but not venous competence. DISCUSSION: Calf muscle pump failure is a therapeutic target in the treatment of CVD. Evidence suggests that isotonic exercise treatment may be an effective method of increasing the hemodynamic performance of the calf muscle pump.
CONCLUSIONS: This review emphasizes the requirement for more attention to be placed on the treatment of calf muscle pump failure in cases of CVD by use of exercise treatment programs or other methods, which may be of clinical importance in managing symptomatic disease. To establish this in routine clinical practice, these results would need to be replicated in appropriate clinical trials. It would also be logical to look at other modifiable muscle pumps, such as the thigh and foot, and to explore the potential benefit of electrical devices acting on the leg (eg, electrical muscular or neuromuscular stimulation), especially for those patients in whom exercise capacity is limited.
Copyright © 2014 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2014        PMID: 26993396     DOI: 10.1016/j.jvsv.2013.10.053

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  10 in total

1.  Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.

Authors:  Damon E Houghton; Alexander Lekah; Thanila A Macedo; David Hodge; Rayya A Saadiq; Yvonne Little; Ana I Casanegra; Robert D McBane; Waldemar E Wysokinski
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

2.  Pilot Trial of Neuromuscular Stimulation in Human Subjects with Chronic Venous Disease.

Authors:  Katherine J Williams; Hayley M Moore; Mary Ellis; Alun H Davies
Journal:  Vasc Health Risk Manag       Date:  2021-12-01

3.  Refractory venous leg ulcers: observational evaluation of innovative new technology.

Authors:  Connie Harris; Amanda Loney; Jillian Brooke; Amanda Charlebois; Lucy Coppola; Sowmil Mehta; Norman Flett
Journal:  Int Wound J       Date:  2017-06-30       Impact factor: 3.315

4.  Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study.

Authors:  Damon E Houghton; Aneel Ashrani; David Liedl; Ramila A Mehta; David O Hodge; Thom Rooke; Paul Wennberg; Waldemar Wysokinski; Robert McBane
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

5.  Supervised exercise protocol for lower limbs in subjects with chronic venous disease: an evaluator-blinded, randomized clinical trial.

Authors:  Esther Fernandes Tinoco Volpe; Vanessa R Resqueti; Ana Aline Marcelino da Silva; Lucien Peroni Gualdi; Guilherme A F Fregonezi
Journal:  Trials       Date:  2020-05-19       Impact factor: 2.279

6.  Effect of different rehabilitation training timelines to prevent shoulder dysfunction among postoperative breast cancer patients: study protocol for a randomized controlled trial.

Authors:  Yu-Wei Shao; Qing Shu; Dan Xu; Hui Teng; Gao-Song Wu; Jin-Xuan Hou; Jun Tian
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

7.  Evaluation of a muscle pump-activating device for non-healing venous leg ulcers.

Authors:  Connie Harris; Rochelle Duong; Gwen Vanderheyden; Beth Byrnes; Renee Cattryse; Ava Orr; David Keast
Journal:  Int Wound J       Date:  2017-08-02       Impact factor: 3.315

8.  'Valves' of the angular vein: Orbicularis oculi, depressor supercilii, and zygomaticus minor.

Authors:  Joe Iwanaga; R Shane Tubbs; Hongtae Kim; Mi-Sun Hur
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

9.  Analysis of the dynamics of venous blood flow in the context of lower limb temperature distribution and tissue composition in the elderly.

Authors:  Aleksandra Skomudek; Iwona Gilowska; Ryszard Jasiński; Krystyna Rożek-Piechura
Journal:  Clin Interv Aging       Date:  2017-08-28       Impact factor: 4.458

10.  A Lower Leg Physical Activity Intervention for Individuals With Chronic Venous Leg Ulcers: Randomized Controlled Trial.

Authors:  Teresa J Kelechi; Margaret A Prentice; Martina Mueller; Mohan Madisetti; Alexey Vertegel
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-15       Impact factor: 4.773

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.